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Abstract
Objectives Many Eastern Mediterranean countries are
undergoing dramatic socioeconomic, demographic and life
style changes and face noncommunicable disease (NCD)
epidemics. We evaluated recent trends in major NCD risk
factors in occupied Palestinian territories (OPT), Turkey,
Syria and Tunisia.
Methods We searched published and unpublished sources
for systolic blood pressure (SBP), diabetes, smoking, body
mass index (BMI), and cholesterol trends for both men and
women aged 35–84 in each country from 1995 to 2009.
Results Smoking prevalence was stable over time in
Tunisia and Syria, but decreasing in Turkey (annual change
-0.9 %) and OPT (annual change -0.7 %). Mean BMI
(annual change of 0.1 % for Turkey, 0.2 % for OPT and
Tunisia and 0.3 % in Syria) and diabetes (annual change of
0.3 % for Turkey, 0.4 % for OPT and Tunisia and 0.7 % in
Syria) prevalence increased in each country. SBP levels
increased slightly in Tunisia and Syria but decreased in
OPT and Turkey.
Conclusions Recent risk factor trends are worrying. Good
quality data on the extent and determinants of NCDs are
essential to respond the changing health needs of popula-
tions with burgeoning NCD epidemics.
Keywords Trend  Risk factors 
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Introduction
Non-communicable diseases (NCDs) impose a large burden
on human health worldwide. WHO defines NCDs as chronic
non-transmissible diseases, generally of long duration and
slow progression. The main types are cardiovascular diseases,
cancers, chronic respiratory diseases (such as chronic
obstructed pulmonary disease and asthma) and diabetes.
Cardiovascular diseases (CVDs) are among the most pre-
valent type of NCDs. In 2010 there were more than 53 million
CVD deaths globally and 65.5 % of all deaths were from
NCDs worldwide (Lozano et al. 2012). The recent Global
Burden of Disease (GBD) study reported that 54 % of dis-
ability adjusted life years (DALYs) worldwide were due to
NCDs in 2010, an increase from 43 % in 1990. NCDs remain
the leading cause of mortality in developed countries,
although remarkable declines have been achieved in mortality
rates in the last 20 years (Lozano et al. 2012). However, the
burden of NCDs is increasing dramatically in low and middle
income countries. In 2008, roughly four out of five NCD
deaths occurred in low- and middle-income countries (WHO
2011b), a sharp increase from the figure reported (just under
40 %) in 1990 (Murray and Lopez 1997; WHO 2011a).
Moreover, NCDs are having an effect on all age groups—
already, one-quarter of all NCD-related deaths are among
people below the age of 60 (WHO 2011a). The rise in the
prevalence of NCDs is the result of complex interactions
between health, economic growth and development, and it is
strongly associated with universal trends such as ageing of the
global population, rapid unplanned urbanization, and the
globalization of unhealthy lifestyles. Major NCD and CVD
risk factors overlap and include tobacco use, lack of physical
activity, and unhealthy dietary patterns. As these behavioural
risk factors can be difficult to measure accurately, resulting
biological risk factors (such as body mass index, blood pres-
sure and blood cholesterol levels) are often additionally
reported. Whilst there are many other genetic and possibly
immunological factors that may influence CVD risk, for the
purposes of this study we are defining CVD risk factors as
those behavioural and biological factors commonly measured
e.g. in WHO STEPS surveys (smoking, physical inactivity,
obesity, diabetes, total cholesterol and blood pressure) which
we can compare over time and across countries (WHO 2011c).
Many Eastern Mediterranean countries are undergoing
demographic and epidemiologic transitions and hence face
NCD epidemics (Motlagh et al. 2009). Indeed, the World
Health Organization (WHO) estimated that the Middle East
and North Africa region would experience the greatest
increase in NCD burden between 2010 and 2020 (WHO
2011b). A meta-analysis of cardiovascular disease (CVD) risk
factors in Middle Eastern countries published in 2009 reported
a high prevalence of obesity, diabetes mellitus, hypertension,
and smoking (Motlagh et al. 2009). The studies included in
this meta-analysis had substantial heterogeneity owing to
differences in methodology and study populations. This study
also only presented cross-sectional data and did not attempt to
assess the recent trends in risk factors within the region. Good
quality epidemiologic data on disease occurrence and risk
factor trends are generally necessary to plan health services, to
determine the public health priorities and respond efficiently
to increasing NCD burden in developing countries. This may
be particularly the case at present in Middle East and North
African (MENA) countries because their health systems are
undergoing transition to adapt both to the changing burden of
disease and economic constraints as well as socio-political
transformation in some countries.
This study was conducted as part of a Seventh Framework
of European Union-funded multinational project titled
MedCHAMPS (Mediterranean Studies of Cardiovascular
disease and Hyperglycaemia: Analytical Modelling of Pop-
ulation Socio-economic transitions). The project aimed to
analyse and model changes in risk factors and CVD mortality
rates in Syria, Occupied Palestinian territories (OPT),
Tunisia and Turkey. http://research.ncl.ac.uk/medchamps/
(Bowman et al. 2012; Maziak et al. 2013). The data presented
here were used partly to generate the IMPACT CHD models
in these four countries (Abu-Rmeileh et al. 2012; Maziak
et al. 2013; Rastam et al. 2012; Saidi et al. 2013; Unal et al.
2013). The aim of this current study was, therefore, to
evaluate recent trends in CVD risk factors in occupied Pal-
estinian territory (OPT), Turkey, Syria and Tunisia based on
the best data available for years 1995–2009.
Methods
Study area
Turkey is located at the crossroads of Europe and Asia with
a population of 76 million; 70 % living in urban areas.
Syria is located to the South of Turkey with 21 million
inhabitants; 56 % living in urban areas (at the time of data
collection, just prior to the start of the uprising). Tunisia
(10.9 million and 67 % living in urban areas population)
and Turkey are considered upper-middle income countries
according to the World Bank whilst Syria and Palestine
(70 % living in urban area) are classified as lower-middle
income countries with a low human development index
value. Turkey is the largest of the countries in this study.
Syria and Tunisia are similar in scale but 4 times smaller
than Turkey (185 and 163 km2 respectively) (WHO 2014).
Target population
In our study adults aged 35–84 formed the target population.
We selected this age band since data are usually not available
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for people over 85 and for comparability with other epide-
miological studies elsewhere (Kuulasmaa et al. 2000). We
gathered data for both men and women separately. This is
important in the specific context of NCDs in the MENA
region due to gender socio-cultural issues which impact
CVD risk factors differently for women and men.
Measurements and indicators
We used mean values [and 95 % confidence intervals (CI)]
for indices that are measurable such as BMI, blood cho-
lesterol, and systolic blood pressure instead of prevalence
rates (of obesity, hypercholesterolaemia or hypertension)
as our main outcome because evidence has demonstrated
that the association between CVD and these risk factors is
continuous (Prospective Studies et al. 2009). For smoking
and diabetes prevalence data were collected. In most cases
there was no data analysis of subject-level data, but only
national or regional age-gender specific values were
available. We contacted study authors to request data or
additional results when the risk factor definitions or age
bands published were not consistent with our definitions.
Data sources and study selection
Data on each risk factor were collected by the research
teams of project countries. Potential data sources including
surveys, national statistics reports or registers were evalu-
ated using a pre-defined data collection form developed
iteratively by the project members. This included the def-
initions and cut off points of risk factors, stratified by
gender and 10 year age group (Electronic supplementary
material (ESM) Appendix 1—Data collection form). These
forms were prepared using information from Preferred
Reporting Items for Systematic Reviews (PRISMA) and
Strengthening the Reporting of Observational studies in
Epidemiology (STROBE) guidelines (Vandenbroucke
et al. 2014). Data on major cardiovascular risk factors
(smoking, diabetes, BMI, total cholesterol and systolic
blood pressure) were searched systematically from inter-
national (MEDLINE/PubMed) and national electronic
databases using specific key words for each risk factor and
partner country. Titles and abstracts were examined for
inclusion by two independent reviewers. Bibliographies of
retrieved articles were scanned for additional articles.
National survey reports and regional studies were also
screened. Websites of national professional associations
such as cardiology, diabetes and internal medicine were
checked in each partner country. Congress abstracts and
reference list of key papers were also checked manually.
Experts working on cardiovascular diseases and diabetes
were contacted to find additional unpublished studies (ESM
Appendix 2- Search method and data sources searched).
Data on study design, participants, diagnostic criteria,
local or national setting (representativeness), study size,
sampling method, bias, strength and weakness of studies
were assessed and extracted in specially designed data
collection forms. Studies were required to conform to the
following criteria: (a) a sample that included adults aged
[25, (b) cohort or cross-sectional design (c) original
studies that presented the data on the prevalence of dia-
betes, smoking, blood pressure levels, total cholesterol
levels or mean BMI values stratified by age and gender
(d) study setting should be national or nationally repre-
sentative. Studies that fulfilled these criteria were used to
estimate the trends.
We included population surveys that used standardized
methods, reported the prevalence or mean values of risk
factors including smoking, systolic blood pressure, diabetes
mellitus, total cholesterol, and BMI. For reporting of
individual risk factors, the following criteria were required:
(a) body mass index (BMI), calculated as weight (kilo-
gram)/height (square metre) and, (b) diabetes mellitus was
defined based on either fasting glucose or glucose tolerance
cut-point (American Diabetes 2011).
A detailed list of data sources from each country and
critical appraisal notes for data sources has been published
elsewhere (Abu-Rmeileh et al. 2012; Maziak et al. 2013;
Rastam et al. 2012; Saidi et al. 2013; Unal et al. 2013) and
is available in ESM Appendix 3 provided with this
manuscript.
Data analysis
BMI calculated as weight (kilogram)/height (square metre),
systolic blood pressure (mmHg) and total cholesterol
(mg/dl) levels were collected as continuous variables and
the change in mean values of these variables were used for
two endpoints. Data on smoking and DM were collected as
rates. Final year rates were standardized for age using the
direct standardization method. Age and gender-specific
rates from study populations were applied to the base year
population distribution based on census data for each
country to eliminate differences in observed rates that may
result from differences in population composition. To make
the trends with different starting points comparable, linear
interpolation was made backward or forward if necessary.
While estimating the changes in risk factors we used the
linear regression method to interpolate missing data for
time points. We assumed the same average annual %
change for age/gender groups. To evaluate the trends in
risk factor levels, 95 % confidence intervals (CI) for base
and final years were presented. Trends were presented by
gender among adults aged between 35 and 84 years, by
10 year age group. Microsoft Excel 2010 software was
used for the analysis.
CVD risk factor trends in the Eastern Mediterranean region
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Results
Country level data were limited in all countries between
1995 and 2009. In OPT a study in both rural and urban
areas of Ramallah governorate was used as the main source
for the early year (1996). In Syria the main data source for
risk factors is Aleppo Diabetes Study (2006). A STEP-
WISE survey was also carried out in Syria in 2003. Tunisia
has risk factor data from surveys carried out in 1976, 1997
and 2009 in main districts including Tunis and Ariana.
Turkey has a national adult CVD risk factor survey carried
out in 1990 (Onat 2001) and the number of national sur-
veys (Altun et al. 2005; Sanisoglu et al. 2006; Satman et al.
2002, 2013) increased substantially in the last 10 years.
Smoking prevalence was high among men at all time
points, ranging from 42 % (Tunisia) to 49 % (OPT) in the
mid-1990s. Smoking prevalence was lower in women,
ranging from 1.8 % (Tunisia) to 11.7 % (Syria) in women.
Smoking prevalence decreased in Turkey and OPT but
persisted in Tunisian men and increased in Syria by the late
2000s. Smoking prevalence reached 52 % in men in 2006
in Syria—the highest among the four countries. Turkey had
the lowest smoking prevalence in men (24.6 %) in 2008. In
the same period smoking prevalence increased by 49 % in
women in Syria and almost doubled in Tunisian women
(from 11.6 %; 95 % CI 9.4–13.8) in 1996 to 17.3 %; 95 %
CI 15.3–19.3 in 2006) (Table 1; ESM Appendix-Fig. 1),
albeit from a low starting level. While the smoking rates
decreased by 0.7 % in OPT and 0.9 % in Turkey annually,
smoking rates increased by 0.4 % in Syria.
In all four countries diabetes prevalence increased among
both men and women over this decade. Syria and Tunisia
experienced the highest increase (approximately 50 %) in
diabetes prevalence in men (Table 1; ESM Appendix-
Fig. 2). In general diabetes prevalence was relatively con-
sistent and high across the four countries; ranging from
17.7 % in OPT to 20 % in Syria in the late 2000s.
Mean BMI increased in all four countries in both men
and women. Syria experienced the highest (11 %) increase
in women. Systolic blood pressure (SBP) showed a
decreasing trend in Turkey (1.9 %) and OPT (1.4 %),
whilst it increased by 6.5 % in Syria over this 10-year
period. In Tunisia mean SBP increased by 3 % in men but
decreased by 2.3 % in women between 1997 and 2009.
Mean total cholesterol decreased in Tunisia and in OPT
and persisted in Turkey. However, cholesterol levels
increased both in men and women in Syria between 1996
and 2006 (Table 2; ESM Appendix-Fig. 5).
Table 1 Changes in smoking and diabetes prevalence in occupied Palestinian territories, Syria, Tunisia and Turkey for period 1995–2009 by
gender
Smoking, % (95 %CI) Diabetes, % (95 %CI)
Men Women Total Men Women Total
Occupied Palestinian territories
1998 49.5 (45.7–57.3) 10.8 (8.7–12.9) 29.4 (27.1–31.7) 13.4 (10.8–16.0) 14.2 (11.8–16.6) 13.8 (12.1–15.5)
2009 39.5 (37.8–41.2) 3.7 (3.2–4.2) 21.5 (20.6–22.4) 18.9 (17.5–20.3) 16.5 (15.5–17.5) 17.7 (16.9–18.5)
% Change -20.2 -65.3 -26.8 40.7 16.3 28.0
Average change/yeara -0.9 -0.6 -0.7 0.5 0.2 0.4
Syria
1996 47.9 (44.1–51.7) 11.6 (9.4–13.8) 27.4 (25.1–29.7) 12.5 (10.0–15.0) 16.0 (13.5–18.5) 14.3 (12.5–16.1)
2006 51.6 (48.9–54.3) 17.3 (15.3–19.3) 31.5 (29.8–33.2) 18.7 (16.8–20.6) 23.1 (21.1–25.1) 20.9 (19.5–22.3)
% Change 7.7 48.7 14.9 49.4 44.4 46.7
Average change/year 0.4 0.6 0.4 0.6 0.7 0.7
Tunisia
1997 42.1 (41.1–43.1) 1.8 (1.5–2.1) 21.7 (21.1–22.3) 13.5 (12.4–14.6) 14.8 (13.9–15.7) 14.1 (13.4–14.8)
2009 37.3 (36.5–38.1) 5.2 (4.9–5.5) 20.9 (20.5–21.5) 20.2 (19.5–20.9) 18.1 (17.6–18.6) 19.1 (18.7–19.5)
% Change -11.4 184.9 -3.8 50.3 22.2 35.3
Average change/year -0.4 0.3 -0.1 0.6 0.3 0.4
Turkey
1995 44.6 (44.0–45.2) 9.6 (9.3–9.9) 27.0 (26.6–27.4) 14.5 (14.1–14.9) 16.2 (15.8–16.6) 15.3 (15.0–15.6)
2008 24.6 (24.1–25.1) 7.2 (6.9–7.5) 15.7 (15.4–16.0) 17.5 (17.0–18.0) 19.9 (19.5–20.3) 18.7 (18.4–19.0)
% Change -44.8 -25.3 -41.9 21.0 22.9 22.2
Average change/year -1.5 -0.2 -0.9 0.3 0.4 0.3
a Value last year of period segment - value first year of period segment)/value first year of period segment
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Discussion
The present study identified and critically appraised exist-
ing data from local CVD risk factor surveys and disease
registers and assessed the change in main risk factors
during last decade in Syria, OPT, Tunisia and Turkey. In
general population statistics and projections were available,
complete, accurate and accessible in the study countries
(Abu-Rmeileh et al. 2012; Rastam et al. 2012; Saidi et al.
2013; Unal et al. 2013).
Good quality, nationally representative data are essential
to evaluate the trends in NCD epidemic and to predict
future trends. However, data on major NCD risk factors
from earlier decades (1980s or early 1990s) are missing in
all the countries except Tunisia. In addition, the quality of
the data and representativeness of the population in older
studies are questionable. For example the well-cited
Turkish Adult Risk Factor Survey did not have a real
sampling frame and the sample was selected from volun-
teers (Onat et al. 1993). The NCD risk factor data from
OPT only; come from West Bank and most data from Syria
come from the Aleppo Diabetes Study. More recently,
WHO STEPWISE surveys seem to provide good national
data for risk factors since they have been carried out using
validated and standardized methods (WHO 2011c).
STEPWISE Surveys done in Syria and OPT by the MOH
and WHO on 2003 and 2006, respectively, are the main
national surveys in these countries. Although Turkey and
Tunisia did not have STEPS surveys these countries had
nationally representative data on NCDs and risk factors
(MOH 2007, 2010; Saidi et al. 2013; Sanisoglu et al. 2006;
Satman et al. 2002, 2013) that could provide epidemiologic
evidence for decision making. It was also possible to obtain
breakdowns by key demographic features including age,
gender, urban/rural location but less so for ethnicity and
socioeconomic status.
These countries showed rapid risk factor and mortality
changes which might be the result of economic and nutri-
tional transitions in the Middle East. In 2012 Human
Development Index (HDI) ranking for OPT, Syria, Tunisia
and Turkey was, respectively, 110, 116, 94 and 90 (over
187 ranked countries); Turkey and Tunisia were counted as
having high human development, while OPT and Syria
have medium development. Between 2010 and 2012
average annual HDI growth was higher in Turkey (0.95),
followed by Tunisia (0.86), and Syria (0.70). Gender
Inequality Index rankings (lower rank means higher gender
inequality) were 118, 46 and 68, respectively, (over 150
ranked countries) (UN 2014). Data for OPT were not
available for these United Nations rankings.
Our analyses demonstrate very heterogeneous trends in
major CVD risk factors, even among neighbouring coun-
tries with shared similar culture and life style. Recent
analyses of global CHD mortality data from the WHO
database have also demonstrated the substantial heteroge-
neity in CHD mortality trends (emergence and waning of
the epidemic) between culturally and geographically sim-
ilar countries (Mirzaei et al. 2009). During the given
periods for each country, CHD mortality in Turkey and
OPT decreased by 25 % in OPT and by 17 % in Turkey,
and CHD mortality rates rose by 30 % in Tunisia and by
56 % in Syria. While similar rises in CHD mortality have
been observed in many other middle income countries,
Turkish CVD mortality rates resemble Central and Eastern
European countries where CVD mortality rates have been
declining over the last two decades (Dinc et al. 2013).
Smoking prevalence remained constant in Tunisia and
Syria but started to decrease in OPT and Turkey. Smoking
prevalence rates are still high in the four countries com-
pared with the countries in America, Europe and Australia
(Ng et al. 2014). Our estimates of trends in smoking are in
the same direction as the GBD 2012 estimates, where
estimated age-standardized prevalence of daily tobacco
smoking declined by 25 % in men and by 42 % in women
between 1980 and 2012 (Ng et al. 2014). In the same study
the mean annualized rate of decline was 2.3 % between
1997 and 2006 in women and 1.8 % in total in developing
countries. Annual rate of decline rates in Turkey, Palestine,
Syria (0.9, 0.7 and 0.1 %) were lower than that reported by
NG et al (2014). This may be because of the difference in
age groups; we analysed data from middle aged and older
adults (age 35?) whilst Ng et al. (2014) included all adults
over 15 years. Declines in smoking rates have been higher
among younger people over the last three decades Ng et al.
The increasing smoking trends in Syrian men and women
and Tunisian women need special attention. The reason for
declining smoking trends in OPT could be due to the
antismoking law which was initiated in 2005 (Abu-Rme-
ileh et al. 2012). According to the Turkish part of Global
Adult Tobacco Survey (GATS) conducted in 2008 and
2012, smoking prevalence significantly decreased among
adults from 31.2 % (16.0 million) in 2008 to 27.1 % (14.8
million) in 2012 in Turkey. This represents a 13.4 % rel-
ative decline in smoking prevalence (13.5 % decline for
males; 13.7 % decline for females) (Kostova et al. 2014).
These findings may be attributed to implementation of
strict tobacco control policies in Turkey. However, in
Syria, lack of effective tobacco control policies and an
unstable political situation could be the reason for the rise
in smoking prevalence (Rastam et al. 2012).
In all countries average BMI is higher than 25 kg/m2
(the definition of overweight), and in three of the four
countries (all except Tunisia) mean BMI in women is
already above 30 kg/m2; the cutoff for obesity (Consulta-
tion 2004). Our analysis showed that the mean BMI
increased by 3, 3, 3 and 2 kg/m2 per decade in Syria, OPT,
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Tunisia and Turkey, respectively. The increase was higher
in men compared with women in Tunisia and Turkey. In
Syria and OPT, women had higher relative increases in
BMI compared with men. Our estimates for mean BMI
trends are similar to those reported by the Global Burden of
Metabolic Risk Factors of Chronic Diseases Collaborating
Group work (Finucane et al. 2011). In that analysis they
reported 0.9 kg/m2 increase in mean BMI per decade in
men and 1.1 kg/m2 increase in women aged 20 years and
older in the Middle East and North Africa Region (Finu-
cane et al. 2011). However, according to our results Syria
showed the highest increase in mean BMI; a 2 kg/m2
increase in men and 3 kg/m2 increase in women over a
decade. A substantial increase in obesity, from 17 to 28 %,
was also reported for Lebanese adult population between
1997 and 2009 (Nasreddine et al. 2012). This increasing
obesity trend is most likely due to rapid economic and
nutritional transitions in this region.
Mean SBP decreased in women in Tunisia, Turkey and
OPT but increased in Syria. A recent analysis also reported
a decreasing trend in mean SBP in the MENA region
between 1980 and 2008 (Danaei et al. 2011).
Mean cholesterol decreased only in OPT by 4.2 %. In
Tunisia and Turkey mean total cholesterol levels changed
by\1 %. In Syria cholesterol levels increased both in men
(by 5.5 %) and women (by 5.8 %) between 1996 and 2006.
Similarly a systematic review that included population
surveys from 199 countries globally concluded that very
little change in mean total cholesterol was observed
between 1980 and 2008; falling by \0.1 mmol/L per
decade in men and women (Farzadfar et al. 2011). While
mean BMI increased in Tunisia, Turkey and OPT, SBP
showed a decreasing trend in these countries and choles-
terol levels decreased or were stable. This could be the
result of increased uptake of treatments in the community
for high blood pressure and hyperlipidemia. Decreases in
smoking and blood pressure levels explained 51 and 48 %
percent of the fall in CHD mortality rates in OPT and
Turkey, respectively (Abu-Rmeileh et al. 2012; Unal et al.
2013). On the other hand increases in SBP in Syria and
Tunisia increased CHD mortality by 32 and 24 %,
respectively, on CHD mortality (Rastam et al. 2012; Saidi
et al. 2013).
This increasing obesity and diabetes trend is most likely
due to rapid economic and nutritional transitions in this
region, in particular, increased consumption of a western-
ized diet such as fast food, and more sedentary lifestyles
following urbanization. For example, between 1971 and
1997, calorie intakes rose by over 40 % in Syria and
Tunisia, (from 2,340 to 3,350 calories in Syria and from
2,280 to 3,280 calories in Tunisia). According to the FAO
statistics, daily calorie intake per capita in 2005–2007 was
3,480 calories in Turkey and 3,310 in Tunisia. Fat intakes
similarly increased by over 60 % over the same time period
(Musaiger 2002). It is also evident that weight gain
(measured as the change in BMI) resulted in higher risk of
developing DM (relative risk was 1.25 for each unit of BMI
gain in adults) (Schienkiewitz et al. 2006). Physical activity
levels are also very low; according to a recent Turkish
study 71.9 % of individuals over the age of 12 did not take
any physical activity in the last week (MOH 2014).
Even modest changes in population risk factor levels may
result in significant changes in population mortality. Coef-
ficients estimated from large meta-analyses of prospective
cohort data, such as the Prospective Studies Cohort Col-
laboration, have estimated the population impact of
relatively small changes in risk factors. For example an
approximate 4 mmHg reduction in SBP (seen in Turkish
women) would be expected to result in about a 20 %
reduction in hazard of CHD mortality at a population level
(Lewington et al. 2002). Similarly, a large meta-analysis has
demonstrated that even small increases in BMI, such as a
1 U increase, would be expected to increase CHD mortality
by 3–4 % in younger adults (Bogers et al. 2007).
This analysis has several strengths. First we performed
comprehensive data searching and critical appraisal of data
sources by the scientists in individual countries. Our search
included unpublished studies and reports. In most cases
age–gender-specific country-level aggregated data were
available. However, in many cases only broad age groups
were available, or results not published yet, and in these
cases we requested and obtained individual study data to
generate the estimates we needed. All data sources were
critically evaluated and statistical methods including linear
interpolation were used to fill in the missing data for time
points assuming the same average annual % change. This
analysis also has several limitations. One potential limita-
tion could be differences between studies including sample
size, study quality, study design, diagnostic criteria, and
geographical distribution in the studies which might have
an impact on risk factor prevalences. Second, using
regional instead of national data for some countries such as
in Syria for different time points may limit the generaliz-
ability of the findings. We did not include two main risk
factors such as physical activity and healthy nutrition
because of scarcity of the data in these countries. For
example there is only one published national study in
Turkey (MOH 2014) measuring these two conditions at
population level. We have assumed a linear increase or
decrease in risk factors. However, trends for prevalences or
mean values may follow less than linear or nonlinear pat-
terns. We have added the 95 % CI for each risk factor
(where available) for the base and final years for each
country. We did not analyse sample data (only cumulative
reported data) which make a more comprehensive evalua-
tion of statistical significance of change in risk factors
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impossible. Last, for each risk factor a different number of
data points were used in this study. For example while
Turkey had four data points for smoking prevalence,
Tunisia and OPT had only two. On the other hand for
estimating blood pressure levels; Turkey used two data
points, but Tunisia had three data points. This might have
an impact on slope of the trends (ESM). Variations in
prevalence of CVD risk factors such as income, education,
urban–rural setting was not assessed in this study, however,
evidence suggest that socioeconomic inequalities exists in
distribution of risk factors and NCDs (Hassoy et al. 2014;
Sozmen and Unal 2014). Another limitation is that
although these countries may have similarities in culture
and lifestyle, they differ in terms of gender inequality and
economic development which may reduce comparability of
trends across countries; however, within country compari-
son is generally more robust.
Conclusion
Existing data already suggest worrying trends especially in
obesity and diabetes that should be taken into account as a
public health emergency in these diverse Eastern Medi-
terranean countries. However, epidemiologic data which is
necessary to respond efficiently to this increasing NCD
burden in developing countries tend to be either nonexis-
tent or limited. Hence, in all countries periodic surveys of
CVD risk factors using standardized and consistent meth-
ods in the general population are required to provide data
for evidence-based policy making to reduce future burden
of NCDs and its risk factors. Policy making also requires
data to support decision modelling and forecasting of
future burden. Decision modelling itself can help in refin-
ing the data needs and helps to set the national priorities in
terms of research by integrating research and decision as a
continuous improvement cycle.
We also recommend developing a web page like the UK
British Heart Foundation’s HeartStats site http://www.
heartstats.org) to present data sources on NCDs and risk
factors for the MEDCHAMPS project countries and for the
countries in the Mediterranean Region. This shared web
source can help the countries to extrapolate the findings to
their own country and support evidence-based health pol-
icy making.
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